F-star Maximizing Platform Tech via Spinout Strategy
By Nuala Moran
Tuesday, October 22, 2013
LONDON – Maximizing value from technology platforms presents formidable challenges for biotechs, in balancing the level of investment in product development with cranking the handle to generate new programs.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.